CAS 73-78-9 Pure Lidocaine Hydrochloride Powder For Local Anesthetic

factory supply lidocaina lidocaine hydrochloride cas 73-78-9 lidocaine hcl lidocaine powder

Product 

Lidocaine hydrochloride is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted by the kidneys. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation. N-dealkylation, a major pathway of biotransformation, yields the metabolites monoethylglycinexylidide and glycinexylidide. The pharmacological/toxicological actions of these metabolites are similar to, but less potent than, those of Lidocaine hydrochloride. Approximately 90% of Lidocaine hydrochloride administered is excreted in the form of various metabolites, and less than 10% is excreted unchanged. The primary metabolite in urine is a conjugate of 4-hydroxy-2,6-dimethylaniline.

COA 

Packing 

1) 1kg/bottle (1kg net weight, 1.1kg gross weight, packed in 1 kg bag.

2) 25kg/drum (25kg net weight, 28kg gross weight)